Company / Total Assets
ResMed Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$8.2B
FY2025
5-year range
$4.7B / $8.2B
FY2021-FY2025
Trend
+18.9%
vs FY2024
Sector context
#42 of 166
Health Care
What the data says
ResMed's total assets of $8.2B is higher than 75% of companies in the Health Care sector (FY2025). Total Assets has increased for 7 consecutive years, from $3.1B in FY2018 to $8.2B in FY2025.
Based on SEC 10-K filings.
$8.2B in FY2025 with a 5-year CAGR of +12.2%. Top quartile in the Health Care sector.
Improved from $6.8B to $8.2B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +17.1%
- 5-Year CAGR
- +12.2%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 166This company $8.2B Sector average $15.0B
▼
-45.4% below sector average
Key checks
Key Insights
- ResMed's total assets has grown for 7 consecutive years.
- 5-year CAGR of +12.2%, indicating consistent growth.
- In FY2025, total assets increased 18.9% year-over-year.
- Ranks #42 out of 166 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.2B | +18.9% |
| FY2024 | $6.9B | +1.8% |
| FY2023 | $6.8B | +32.5% |
| FY2022 | $5.1B | +7.8% |
| FY2021 | $4.7B | +3.1% |
| FY2020 | $4.6B | +11.7% |
| FY2019 | $4.1B | +34.1% |
| FY2018 | $3.1B | -11.7% |
| FY2017 | $3.5B | +6.5% |
| FY2016 | $3.3B | +49.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026